https://tissuepathology.com Educational and informative Tue, 08 Sep 2026 12:10:37 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/09/08/lunit-unveils-new-ai-powered-tumor-microenvironment-insights-in-lung-cancer-at-wclc-2026/ Tue, 08 Sep 2026 12:10:37 +0000 https://tissuepathology.com/?p=24663 SEOUL, SOUTH KOREA, September 8, 2026 — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced the presentation of three studies at the 2026 World Conference on Lung Cancer (WCLC 2026), to be held in Seoul, South Korea, from September 12 to 15. Across the three studies, Lunit researchers and […]

The post Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026 first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/09/03/hamamatsu-receives-fda-510k-clearance-for-nanozoomer-s20md-and-s540md-slide-scanner-systems/ Thu, 03 Sep 2026 12:53:02 +0000 https://tissuepathology.com/?p=24656 Hamamatsu: New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ — Hamamatsu Photonics K.K. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the NanoZoomer S20MD and NanoZoomer S540MD Slide scanner systems. Building on the previously […]

The post Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/09/02/lumea-treatmentgps-launches-alpine-path-integration-in-lumeas-platform-bringing-ai-powered-treatment-guidance-into-reports/ Wed, 02 Sep 2026 12:39:17 +0000 https://tissuepathology.com/?p=24653 Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ — Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a physician-built AI platform for clinical decision support and patient education, today announced the Alpine Path integration into Lumea’s software. This integration enables guideline-based treatment guidance […]

The post Lumea: TreatmentGPS Launches Alpine Path Integration in Lumea’s Platform, Bringing AI-Powered Treatment Guidance Into Reports first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/09/01/leica-biosystems-shares-collaboration-with-mindpeak/ Tue, 01 Sep 2026 12:36:03 +0000 https://tissuepathology.com/?p=24650 From Leica Biostystems on LinkedIn: We’re excited to share the next milestone in our collaboration with Mindpeak bringing powerful AI tools closer to researchers through the Aperio AI Store. Six Mindpeak algorithms are now available on the Aperio AI Store, expanding access to AI-powered biomarker and tissue analysis applications within the Leica Biosystems digital pathology […]

The post Leica Biosystems Shares Collaboration With Mindpeak first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/08/31/formapath-mecademic-showcases-the-meca500-powering-formapaths-ntoto/ Mon, 31 Aug 2026 12:26:46 +0000 https://tissuepathology.com/?p=24648 From the FormaPath blog: FormaPath was honored to be featured by Mecademic Industrial Robotics, highlighting the integration of the Meca500 robotic arm within the nToto platform. By combining Mecademic’s micrometer-level precision robotics with FormaPath’s AI-driven automation, nToto delivers a fully automated workflow for small biopsy grossing, improving consistency, traceability, and laboratory efficiency. We’re proud of […]

The post FormaPath: Mecademic Showcases the Meca500 Powering FormaPath’s nToto first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/08/28/indica-labs-boston-university-digital-pathology-core-case-study/ Fri, 28 Aug 2026 11:50:13 +0000 https://tissuepathology.com/?p=24645 From Indica Labs: No matter their organizational setting, digital pathology cores routinely provide researchers with access to advanced imaging and analysis capabilities and institutional expertise that expand the possibilities of scientific studies. The Boston University Digital Pathology Core supports researchers across BU’s Alzheimer’s Disease Research Center, Chronic Traumatic Encephalopathy Center, Boston Medical Center, and broader […]

The post Indica Labs: Boston University Digital Pathology Core Case Study first appeared on Tissuepathology.com.]]>